Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.33 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | TSHR | P16473 | 5/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8190900 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| SCHEMBL25360523 | 0.96 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| SCHEMBL218376 | 0.96 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Hydrochloric Acid SCHEMBL7053060 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| SCHEMBL1618436 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Water SCHEMBL11249940 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Methane SCHEMBL10860324 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| SCHEMBL1563447 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Iodide SCHEMBL1031720 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 | |
| Iodide SCHEMBL8196947 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ALOX12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7008899-B2 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2006-03-07 | — | — | US | claimed |
| US-20050038215-A1 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2005-02-17 | — | — | US | claimed |
| US-5126406-A | Polyoxazolidones of good heat resistance and impact strength | NIPPON PAINT CO., LTD. (JP) | 1992-06-30 | — | — | US | claimed |
| EP-0444956-A2 | Thermosetting resin composition and article obtained therefrom | NIPPON PAINT CO., LTD. (JP) | 1991-09-04 | — | — | EP | claimed |
| EP-4737441-A1 | METHOD FOR PRODUCING ELECTROPHILIC SUBSTITUTED AROMATIC COMPOUND | FUJIFILM Corporation (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260070931-A1 | METHOD FOR MANUFACTURING ELECTROPHILIC SUBSTITUTED AROMATIC COMPOUND | FUJIFILM CORPORATION (JP) | 2026-03-12 | — | — | US | disclosed |
| WO-2025004786-A1 | METHOD FOR PRODUCING ELECTROPHILIC SUBSTITUTED AROMATIC COMPOUND | 富士フイルム株式会社 | 2025-01-02 | — | — | WO | disclosed |
| EP-2216312-B1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | M TECHNIQUE CO LTD (JP) | 2019-05-01 | — | — | EP | disclosed |
| EP-2371831-B1 | PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND | NIPPON SODA CO (JP) | 2016-09-07 | — | — | EP | disclosed |
| US-9133098-B2 | Process for producing organolithium compound and process for producing substituted aromatic compound | NIPPON SODA CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-20150080581-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | RIMTEC CORPORATION (JP) | 2015-03-19 | — | — | US | disclosed |
| US-20150025276-A1 | PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND | NIPPON SODA CO., LTD. (JP) | 2015-01-22 | — | — | US | disclosed |
| US-5329035-A | Biosynthesis of prostaglandins | TEIJIN LIMITED (JP) | 1994-07-12 | — | — | US | disclosed |
| US-5126406-A | Polyoxazolidones of good heat resistance and impact strength | NIPPON PAINT CO., LTD. (JP) | 1992-06-30 | — | — | US | disclosed |
| US-5126423-A | Forming heat-resistant moldings of polyoxazolidones; catalyst selectivity | NIPPON PAINT CO., LTD. (JP) | 1992-06-30 | — | — | US | disclosed |
| US-5086152-A | Complex of organs antimory halide and zinc ralide as catalyst | NIPPON PAINT CO., LTD. (JP) | 1992-02-04 | — | — | US | disclosed |
| EP-0444956-A2 | Thermosetting resin composition and article obtained therefrom | NIPPON PAINT CO., LTD. (JP) | 1991-09-04 | — | — | EP | disclosed |
| EP-0412759-A2 | Heat-curable type resinous composition and moulded article prepared therefrom | NIPPON PAINT CO., LTD. (JP) | 1991-02-13 | — | — | EP | disclosed |
| EP-0342064-A2 | A thermosetting resinous composition and preparation of heat resisting coating and molded product using said composition | NIPPON PAINT CO., LTD. (JP) | 1989-11-15 | — | — | EP | disclosed |
| US-4148814-A | Process for preparing monohydrocarbyltin trihalides | PENNWALT CORPORATION (US) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080581-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | APEX1, SOD1, AP1M1 | ACHE 1137/4885SLC6A2 4440/4885ALDH1A1 1713/4885 |
| US-20260070931-A1 | METHOD FOR MANUFACTURING ELECTROPHILIC SUBSTITUTED AROMATIC COMPOUND | TRPA1, ALK, MAFK | ACHE 2689/4885SLC6A2 3227/4885ALDH1A1 1599/4885 |
| US-20150025276-A1 | PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND | C9, TRPA1, PKD1 | ACHE 3866/4885SLC6A2 4427/4885ALDH1A1 4118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.